Live Breaking News & Updates on Dystrophy Research|Page 5

Stay updated with breaking news from Dystrophy research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sarepta Duchenne gene therapy heads to FDA advisory meeting

Advisers to the U.S. Food and Drug
Administration will discuss Sarepta Therapeutics Inc s
gene therapy for Duchenne muscular dystrophy at a
closely-watched meeting on Friday, days after the agency. | May 12, 2023 ....

Peter Marks , Joseph Schwartz , Manas Mishra , Leroy Leo , National Organization For Rare Disorders , Drug Administration , Sarepta Therapeutics Inc , National Organization , Rare Disorders , Bill Berkrot , Sarepta Therapeutics , Nc Stock Exchange , Press Release , He Srpt Us8036071004 ,

Capricor Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

-Enrollment Continues to Progress in HOPE-3, the Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy ; On Track to Report Interim Analysis in Fourth Quarter of 2023- -Plan to. | May 11, 2023 ....

San Diego , United States , Joyce Allaire , Linda Marb , Raquel Cona , Exosome Platform Technology , Capricor Therapeutics Inc , Nippon Shinyaku Co Ltd , World Vaccine Congress , Globenewswire Inc , Capricor Company Contact , Clinical Research Forum , Duchenne Muscular Dystrophy Program , Exchange Commission , Lifesci Advisors , Strategic Communications , Top Ten Clinical Research Achievement Award , Enrollment Continues , Duchenne Muscular Dystrophy , Report Interim Analysis , Fourth Quarter , Label Extension Data , Second Quarter , Webcast Today , Recent Operational , Muscular Dystrophy Program ,

Odisha govt sanctions financial aid of Rs 10 lakh for each patient suffering from Duchenne Muscular Dystrophy

Bhubaneswar, May 6: Extending financial support to the patients suffering from Duchenne Muscular Dystrophy (DMD), the state government has allowed one-time financial assistance of Rs 10 lakhs to each discharged patient for meeting the requirements towards electric wheelchair, appropriate physiotherapy, genetic test and treatments in higher super speciality institutions. ....

Duchenne Muscular Dystrophy , Odisha Govt Sanctions Financial Aid Of Rs 10 Lakh For Each Patient Suffering From Duchenne Muscular Dystrophy ,

Odisha govt sanctions financial aid of Rs 10 lakh for each patient suffering from Duchenne Muscular Dystrophy

Extending financial support to the patients suffering from Duchenne Muscular Dystrophy (DMD), the state government has allowed one-time financial assistance of Rs 10 lakhs to each discharged patient for meeting the requirements towards electric wheelchair, appropriate physiotherapy, genetic test and treatments in higher super speciality institutions. ....

Public Health Officer , Department Of Health , Duchenne Muscular Dystrophy , Family Welfare , Chief District Medical , Public Health , Chief Minister , Ews India ,

AMO Pharma Limited: AMO Pharma Announces Completion of Treatment of Last Patient in Pivotal REACH-CDM Clinical Trial in Myotonic Dystrophy

Company on track to present first data from REACH-CDM trial in July 2023. LONDON, April 25, 2023 /PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company ....

United Kingdom , City Of , New Zealand , Ibs Mahmood , Nicholas Johnson , Caitlin Oreilly , Commission On Human Medicines , Virginia Commonwealth University School Of Medicine , Drug Developers , Berry Company Public Relations , Department Of Neurology , Myotonic Dystrophy Foundation On , Pharma Limited , Chief Executive Officer , Virginia Commonwealth University School , Principal Investigator , Myotonic Dystrophy Foundation , Human Medicines ,